VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

BTOG 2020 | Checkpoint inhibitor resistance in lung cancer

Kenneth O’Byrne, MD, MB, BCh, BAO, Princess Alexandra Hospital & Queensland University of Technology, Woolloongabba, Australia, discusses checkpoint inhibitor resistance in lung cancer and where things may move forward in this field. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter